IP Library Granted Patent US 9,089,506
Granted Patent B2
US 9,089,506 · App. 13/778,696 · Granted Jul 28, 2015

Stable, non-irritating topical formulations of hydroquinone

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,089,506
App. No.
13/778,696
Granted
Jul 28, 2015
Kind
B2
Abstract

Described herein are methods and compositions for increasing the efficacy and decreasing the irritancy of topical formulations of hydroquinone.

Claims (262)

1. A method for increasing the efficacy of a hydroquinone-containing formulation, the formulation comprising an oil-in-water emulsion, comprising the step of adding a plurality of activating agents to the continuous phase of the formulation in an amount of about 8.5 to about 14.5% by weight of the formulation, thereby forming an improved hydroquinone containing formulation, wherein the activating agent is selected from the group consisting of niacinamide, alpha-arbutin, kojic acid, 1-methylhydantoine-2-imide, algae/mugwort extract, saccharomyces /xylinum/black tea ferment, palmaria palmate extract, brassica napus extract, hexapeptide-2 , glycrrhiza glabra root extract, and combinations thereof.

2. The method of claim 1 , wherein the improved hydroquinone-containing formulation, upon application to the skin of affected subjects, shows improvement from baseline after 12 weeks in overall photodamage in at least about 90% of the subjects.

3. The method of claim 1 , wherein the improved hydroquinone-containing formulation, upon application to the skin of affected subjects, shows improvement from baseline after 12 weeks in mottled pigmentation in at least about 95% of the subjects.

4. The method of claim 1 , wherein the improved hydroquinone-containing formulation, upon application to the skin of affected subjects, shows improvement from baseline after 12 weeks in color in at least about 96% of the subjects.

5. The method of claim 1 , wherein the improved hydroquinone-containing formulation, upon application to the skin of affected subjects, shows an average of at least about 18% improvement from baseline after 12 weeks in overall photodamage.

6. The method of claim 1 , wherein the improved hydroquinone-containing formulation, upon application to the skin of affected subjects, shows an average of at least about 25% improvement from baseline after 12 weeks in mottled pigmentation.

7. The method of claim 1 , wherein the improved hydroquinone-containing formulation, upon application to the skin of affected subjects, shows an average of at least about 23% improvement from baseline after 12 weeks in color.

8. The method of claim 1 , wherein the improved hydroquinone-containing formulation further comprises surfactants and co-surfactants, in an amount of about 4.0 to about 10.0% by weight of the formulation, selected from the group consisting of ceteth-20, steareth-20, cetyl alcohol, glyceryl stearate, PEG-75 stearate, cetearyl alcohol and polyglyceryl-3 esters of acacia decurrents /jojoba/sunflower seed wax.

9. The method of claim 1 , wherein the improved hydroquinone-containing formulation further comprises emollients, in an amount of about 10.0 to about 19.0% by weight of the formulation, selected from the group consisting of cyclomethicone, isononyl isononoate, C 12 -C 15 alkyl ethylhexanoate, dimethicone/divinyldimethicone/silsesquioxane crosspolymer, moringa oleifera seed oil, dimethicone, punica granatum seed oil, rubus occidentalis seed oil, vaccinium macrocarpon seed oil, citrullus lanatus seed oil, rubus idaeus seed oil, salvia hispanica seed oil, jojoba esters, moringa oil/hydrogenated moringa oil esters, and butyrospermum parkii butter.

10. The method of claim 1 , wherein the improved hydroquinone-containing formulation further comprises humectants, in an amount of about 5.5 to about 9.5% by weight of the formulation, selected from the group consisting of pentylene glycol, glycerin and sodium hyaluronate.

11. The method of claim 1 , wherein the improved hydroquinone-containing formulation further comprises thickeners, in an amount of about 0.7 to about 2.0% by weight of the formulation, selected from the group consisting of magnesium aluminum silicate, xanthan gum, dextran and hydroxyethylcellulose.

12. The method of claim 1 , wherein the improved hydroquinone-containing formulation further comprises preservatives, in an amount of about 0.5 to about 3.5% by weight of the formulation, selected from the group consisting of chlorphenesin, sodium bisulfite, sodium sulfite, tocopheryl acetate, citric acid, potassium sorbate, sodium benzoate, BHT, disodium EDTA and phenoxyethanol.

13. The method of claim 1 , wherein the improved hydroquinone-containing formulation further comprises anti-irritants, in an amount of about 0.5 to about 3.5% by weight of the formulation, selected from the group consisting of panthenol, avena sativa kernel extract, allantoin, bisabolol and stearyl glycyrrhetinate.

14. The method of claim 1 , wherein the improved hydroquinone-containing formulation further comprises: surfactants and co-surfactants, in an amount of about 4.0 to about 10.0% by weight of the formulation; emollients, in an amount of about 10.0 to about 19.0% by weight of the formulation; humectants, in an amount of about 5.5 to about 9.5% by weight of the formulation; thickeners, in an amount of about 0.7 to about 2.0% by weight of the formulation; preservatives, in an amount of about 0.5 to about 3.5% by weight of the formulation; anti-irritants, in an amount of about 0.5 to about 3.5% by weight of the formulation; and water, in an amount of about 50.0 to about 60.0% by weight of the formulation.

15. The method of claim 1 , wherein the improved hydroquinone-containing formulation consists essentially of, by weight of the formulation:

purified water

from about 30% to about 70%

hydrofluorocarbon 227ea

from about 6% to about 18%

pentylene glycol

from about 3% to about 7%

cyclomethicone

from about 3% to about 7%

niacinamide

from about 2% to about 6%

isononyl isononoate

from about 1% to about 4%

C12-C15 alkyl ethylhexanoate

from about 1% to about 4%

glycerin

from about 1% to about 3%

hydroquinone

from about 1% to about 3%

alpha-arbutin

from about 1% to about 3%

dimethicone/divinyldimethicone/

from about 1% to about 3%

silsesquioxane crosspolymer

moringa oleifera seed oil

from about 1% to about 3%

glyceryl stearate

from about 1% to about 3%

cetyl alcohol

from about 1% to about 3%

dimethicone

from about 0.5% to about 1.5%

cetearyl alcohol

from about 0.5% to about 1.5%

kojic acid

from about 0.5% to about 1.5%

panthenol

from about 0.5% to about 1.5%

1-methylhydantoine-2-imide

from about 0.5% to about 1.5%

algae extract and mugwort

from about 0.5% to about 1.5%

( artemisia vulgaris ) extract

magnesium aluminum silicate

from about 0.5% to about 1.5%

peg-75 stearate

from about 0.5% to about 1.5%

avena sativa (oat) kernel extract

from about 0.1% to about 1.0%

saccharomyces / xylinum /black tea

from about 0.2% to about 0.6%

ferment

palmaria palmata extract

from about 0.1% to about 0.4%

brassica napus extract

from about 0.3% to about 1.0%

punica granatum (pomegranate)

from about 0.1% to about 0.4%

seed oil

rubus occidentalis (black

from about 0.1% to about 0.4%

raspberry) seed oil

vaccinium macrocarpon

from about 0.1% to about 0.4%

(cranberry) seed oil

citrullus lanatus (watermelon)

from about 0.01% to about 0.05%

seed oil

rubus idaeus (raspberry) seed oil

from about 0.01% to about 0.05%

salvia hispanica (chia) seed oil

from about 0.01% to about 0.05%

tetrahexadecyl ascorbate

from about 0.3% to about 0.7%

ceteth-20

from about 0.2% to about 0.6%

steareth-20

from about 0.2% to about 0.6%

allantoin

from about 0.3% to about 0.7%

chlorphenesin

from about 0.1% to about 0.4%

hexapeptide-2

from about 0.1% to about 1.0%

jojoba esters

from about 0.1% to about 0.4%

moringa oil/hydrogenated

from about 0.1% to about 0.4%

moringa oil esters

bisabolol

from about 0.1% to about 0.3%

fragrance

from about 0.1% to about 0.3%

sodium bisulfite

from about 0.02% to about 0.07%

sodium sulfite

from about 0.02% to about 0.07%

tocopheryl acetate

from about 0.05% to about 0.15%

xanthan gum

from about 0.05% to about 0.15%

citric acid

from about 0.1% to about 0.3%

potassium sorbate

from about 0.1% to about 0.3%

sodium benzoate

from about 0.1% to about 0.3%

dextran

from about 0.1% to about 1.0%

sodium hyaluronate

from about 0.005% to about 0.015%

BHT

from about 0.1% to about 0.3%

stearyl glycyrrhetinate

from about 0.05% to about 0.15%

disodium EDTA

from about 0.05% to about 0.15%

phenoxyethanol

from about 0.01% to about 0.10%

hydroxyethylcellulose

from about 0.1% to about 1.0%

glycyrrhiza glabra (licorice)

from about 0.02% to about 0.07%

root extract.

16. The method of claim 1 , wherein the improved hydroquinone-containing formulation consists essentially of, by weight of the formulation:

purified water

from about 30% to about 70%

hydrofluorocarbon 227ea

from about 6% to about 18%

pentylene glycol

from about 3% to about 7%

cyclomethicone

from about 1% to about 2%

niacinamide

from about 2% to about 6%

isononyl isononoate

from about 1% to about 3%

C 12 -C 15 alkyl ethylhexanoate

from about 1% to about 3%

glycerin

from about 1% to about 3%

hydroquinone

from about 1% to about 3%

alpha-arbutin

from about 1% to about 3%

dimemicone/divinyldimethicone/

from about 1% to about 3%

silsesquioxane crosspolymer

glyceryl stearate

from about 1% to about 3%

cetyl alcohol

from about 1% to about 3%

dimethicone

from about 0.5% to about 1.5%

cetearyl alcohol

from about 0.5% to about 1.5%

kojic acid

from about 0.5% to about 1.5%

panthenol

from about 0.5% to about 1.5%

1-methylhydantoine-2-imide

from about 0.5% to about 1.5%

algae extract and mugwort

from about 0.5% to about 1.5%

( artemisia vulgaris ) extract

magnesium aluminum silicate

from about 0.5% to about 1.5%

PEG-75 stearate

from about 0.5% to about 1.5%

avena sativa (oat) kernel extract

from about 0.1% to about 1.0%

saccharomyces / xylinum /black tea

from about 1% to about 4%

ferment

palmaria palmata extract

from about 0.1% to about 0.5%

brassica napus extract

from about 0.04% to about 0.1%

punica granatum (pomegranate)

from about 0.3% to about 0.9%

seed oil

rubus occidentalis (black

from about 0.3% to about 0.9%

raspberry) seed oil

vaccinium macrocarpon

from about 0.3% to about 0.9%

(cranberry) seed oil

citrullus lanatus (watermelon)

from about 0.06% to about 0.13%

seed oil

rubus idaeus (raspberry) seed oil

from about 0.06% to about 0.13%

salvia hispanica (chia) seed oil

from about 0.06% to about 0.13%

tetrahexadecyl ascorbate

from about 0.2% to about 0.7%

cetem-20

from about 0.1% to about 0.5%

steareth-20

from about 0.1% to about 0.5%

allantoin

from about 0.2% to about 0.7%

chlorphenesin

from about 0.1% to about 0.5%

hexapeptide-2

from about 0.1% to about 1.0%

bisabolol

from about 0.1% to about 0.3%

fragrance

from about 0.1% to about 0.3%

sodium bisulfite

from about 0.02% to about 0.07%

sodium sulfite

from about 0.02% to about 0.07%

tocopheryl acetate

from about 0.2% to about 0.7%

xanthan gum

from about 0.05% to about 0.15%

citric acid

from about 0.05% to about 0.20%

potassium sorbate

from about 0.05% to about 0.20%

sodium benzoate

from about 0.05% to about 0.20%

dextran

from about 0.1% to about 1.0%

sodium hyaluronate

from about 0.005% to about 0.015%

bht

from about 0.1% to about 0.3%

stearyl glycyrrhetinate

from about 0.05% to about 0.15%

disodium edta

from about 0.05% to about 0.15%

phenoxyethanol

from about 0.05% to about 0.1%

hydroxyethylcellulose

from about 0.1% to about 1.0%

glycyrrhiza glabra (licorice)

from about 0.02% to about 0.07%

root extract

acacia decurrens /jojoba/

from about 1% to about 3%

sunflower seed wax polyglyceryl-

3 esters

butyrospermum parkii (shea)

from about 1% to about 3%

butter.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 22, 2016
From: PRECISION DERMATOLOGY, INC.
To: SHAMROC, INC.
Reel/Frame 037562/0479 →
RELEASE OF SECURITY INTEREST Recorded Dec 28, 2015
From: BARCLAYS BANK PLC
To: PRECISION DERMATOLOGY, INC.
Reel/Frame 037365/0438 →
SECURITY AGREEMENT Recorded Jul 6, 2015
From: ECR PHARMACEUTICALS CO., INC.; PRECISION DERMATOLOGY, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 036091/0257 →
RELEASE OF SECURITY INTEREST Recorded Jul 7, 2014
From: GCI CAPITAL MARKETS, LLC
To: PRECISION DERMATOLOGY, INC.
Reel/Frame 033280/0556 →
SECURITY AGREEMENT Recorded Sep 20, 2013
From: PRECISION DERMATOLOGY, INC.
To: GCI CAPITAL MARKETS LLC
Reel/Frame 031249/0011 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2013
From: GURGE, RONALD M.; TRUMBORE, MARK W.; HIRANI, NUPOOR DEVRAJBHAI
To: PRECISION DERMATOLOGY, INC.
Reel/Frame 030882/0765 →